Dr. Donoghue is a lead medical officer in the Division of Oncology Products 2 in the Office of Hematology and Oncology Products in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA).
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy